Publicaciones en colaboración con investigadores/as de Stanford University (10)

2024

  1. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, pp. 1-8

  2. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial

    JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335

  3. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

    JAMA, Vol. 331, Núm. 9, pp. 750-763

  4. Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

    The Lancet, Vol. 403, Núm. 10428, pp. 731-740

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of Endovascular Thrombectomy vs Medical Management with Functional and Safety Outcomes in Patients Treated beyond 24 Hours of Last Known Well: The SELECT Late Study

    JAMA Neurology, Vol. 80, Núm. 2, pp. 172-182

  3. Trial of Endovascular Thrombectomy for Large Ischemic Strokes.

    New England Journal of Medicine, Vol. 388, Núm. 14, pp. 1259-1271

2022

  1. Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort

    Annals of Neurology, Vol. 92, Núm. 3, pp. 364-378

2021

  1. SELECTion criteria for large core trials: Dogma or data?

    Journal of NeuroInterventional Surgery

2019

  1. Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 17, pp. 8463-8470